4.2 Article

Adult diagnosis of congenital serine biosynthesis defect: A treatable cause of progressive neuropathy

Journal

AMERICAN JOURNAL OF MEDICAL GENETICS PART A
Volume 185, Issue 7, Pages 2102-2107

Publisher

WILEY
DOI: 10.1002/ajmg.a.62245

Keywords

ichthyosis; inborn errors of metabolism; progressive neuropathy; serine; sphingolipids

Funding

  1. Common Fund of the NIH Office of the Director
  2. Intramural Research Program of the National Human Genome Research Institute

Ask authors/readers for more resources

A woman with a rare phosphoserine aminotransferase deficiency was successfully treated with high dose oral L-serine, resulting in complete resolution of ichthyosis. Early diagnosis and treatment are crucial in halting neurodegeneration progression and improving neurological disabilities.
A woman with ichthyosis, contractures, and progressive neuropathy represents the first case of phosphoserine aminotransferase deficiency diagnosed and treated in an adult. She has novel compound heterozygous mutations in the gene PSAT1. Treatment with high dose oral L-serine completely resolved the ichthyosis. Consideration of this diagnosis is important because early treatment with L-serine repletion can halt progression of neurodegeneration and potentially improve neurological disabilities. As exome sequencing becomes more widely implemented in the diagnostic evaluation of progressive neurodegenerative phenotypes, adult neurologists and geneticists will increasingly encounter later onset manifestations of inborn errors of metabolism classically considered in infancy and early childhood.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available